The significance of upfront autologous stem cell transplantation for high-intermediate/high-risk stage IV diffuse large B-cell lymphoma.

Autor: Koviazin AK; Department of Hematology and Chemotherapy with Intensive Care Unit, NMRC of Oncology n.a. N.N.Petrov of MoH of Russia, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation.; Department of Innovative Methods in Therapeutic Oncology and Rehabilitation, NMRC of Oncology n.a. N.N.Petrov of MoH of Russia, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation., Filatova LV; Department of Hematology and Chemotherapy with Intensive Care Unit, NMRC of Oncology n.a. N.N.Petrov of MoH of Russia, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation.; Department of Innovative Methods in Therapeutic Oncology and Rehabilitation, NMRC of Oncology n.a. N.N.Petrov of MoH of Russia, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation.; Department of Oncology, Federal State Budgetary Educational Institution of Higher Education 'North-Western State Medical University named after I.I. Mechnikov' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation., Zyuzgin IS; Department of Hematology and Chemotherapy with Intensive Care Unit, NMRC of Oncology n.a. N.N.Petrov of MoH of Russia, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation., Artemyeva AS; Laboratory of Tumor Morphology, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation., Poliatskin IL; Laboratory of Tumor Morphology, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation., Burda DS; Laboratory of Tumor Morphology, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation., Volchenkov SA; Department of Hematology and Chemotherapy with Intensive Care Unit, NMRC of Oncology n.a. N.N.Petrov of MoH of Russia, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation., Elkhova SS; Department of Hematology and Chemotherapy with Intensive Care Unit, NMRC of Oncology n.a. N.N.Petrov of MoH of Russia, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation., Semiglazova TY; Department of Innovative Methods in Therapeutic Oncology and Rehabilitation, NMRC of Oncology n.a. N.N.Petrov of MoH of Russia, Federal State Budgetary Institution 'Petrov National Medical Cancer Research Centre' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation.; Department of Oncology, Federal State Budgetary Educational Institution of Higher Education 'North-Western State Medical University named after I.I. Mechnikov' of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russian Federation.

Publikováno v: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2023 Apr; Vol. 6 (4), pp. e1786. Date of Electronic Publication: 2023 Feb 28.